| Page 258 | Kisaco Research
  • Understand how leaders across sectors are harnessing the opportunity of addressing women’s health
  • Learn where the opportunities are to reap the health and economic returns of closing the gap
  • Get strategic insights on where the health of women market is heading – and how stakeholders can stay ahead
Innovation and Investment
Healthcare Costs and Outcomes

Author:

Fadesola Adetosoye

Associate Partner, McKinsey & Company & Affiliated Leader
McKinsey Institute for Economic Mobility

Fadesola Adetosoye

Associate Partner, McKinsey & Company & Affiliated Leader
McKinsey Institute for Economic Mobility
 

Lina Quinten

Director- European Patent Attorney
Fresenius Kabi Biosimilars

Lina Quinten

Director- European Patent Attorney
Fresenius Kabi Biosimilars

Lina Quinten

Director- European Patent Attorney
Fresenius Kabi Biosimilars
 

Leena Karttunen Contarinom

Senior Director IP
BioNTech

Leena Karttunen Contarinom

Senior Director IP
BioNTech

Leena Karttunen Contarinom

Senior Director IP
BioNTech
 

Heli Pihlajamaa

Principal Director
EPO

Heli Pihlajamaa

Principal Director
EPO

Heli Pihlajamaa

Principal Director
EPO
 

Niklas Wallsargård

CEO and Co-founder
Improvin’

Niklas Wallsargård is the CEO and Co-founder of Improvin’, a technology company tackling the critical global challenge: how to produce more food, more sustainably.

Improvin’ provides food and beverage brands, mills, and processors with the digital infrastructure to collect primary data, quantify sustainability insights, and drive positive impact within their supply chains, together with supplying partners and farmers.

Niklas Wallsargård

CEO and Co-founder
Improvin’

Niklas Wallsargård

CEO and Co-founder
Improvin’

Niklas Wallsargård is the CEO and Co-founder of Improvin’, a technology company tackling the critical global challenge: how to produce more food, more sustainably.

Improvin’ provides food and beverage brands, mills, and processors with the digital infrastructure to collect primary data, quantify sustainability insights, and drive positive impact within their supply chains, together with supplying partners and farmers.

Today, Improvin’ is recognized as one of Europe’s fastest-growing agri-food tech companies, trusted by industry leaders such as Mondelēz International, Barilla, AAK, and Oatly to achieve measurable and scalable sustainability impacts.

Drawing on over a decade of experience in the industry, Niklas is a strong advocate of leveraging smart technology to advance transparency and sustainability across the agri-food sector. His expertise lies in fostering cross-supply chain collaboration and empowering stakeholders to utilize technology for building a more resilient and biodiverse food system.

 

 

Claudette Fuller

Vice President, Non Clinical Safety & Toxicology
Genmab

Claudette Fuller

Vice President, Non Clinical Safety & Toxicology
Genmab

Claudette Fuller

Vice President, Non Clinical Safety & Toxicology
Genmab